Proposed partial amendments to the "Standard on Pharmaceutical Equivalence Test"; (5 page(s), in Korean)

Proposed establishment of the "Regulations on Risk Management Plan operation, etc."; (15 page(s), in Korean)

Draft Food and Drug Administration (FDA) Circular "Guidelines for the Importation and Exportation of Finished Drug Products and Raw Materials"; (6 page(s), in English)